Kontour Ebitda from 2010 to 2024
| 688314 Stock | 28.05 0.95 3.28% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 122.8 M | Current Value 87.4 M | Quarterly Volatility 19.2 M |
Check Kontour Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kontour Medical's main balance sheet or income statement drivers, such as Tax Provision of 13.7 M, Net Interest Income of 2.2 M or Interest Income of 3.3 M, as well as many indicators such as . Kontour financial statements analysis is a perfect complement when working with Kontour Medical Valuation or Volatility modules.
Kontour | Ebitda |
Currently Active Assets on Macroaxis
Other Information on Investing in Kontour Stock
Kontour Medical financial ratios help investors to determine whether Kontour Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kontour with respect to the benefits of owning Kontour Medical security.